Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS)-Reference-Cited by-同舟云学术

Experimental Autoimmune Encephalomyelitis (EAE) as Animal Models of Multiple Sclerosis (MS)

Published:2018-01-08 Issue:11 Volume:8 Page:a028977
ISSN:2157-1422
Container-title:Cold Spring Harbor Perspectives in Medicine
language:en
Short-container-title:Cold Spring Harb Perspect Med

Author:

Glatigny Simon,Bettelli Estelle

Publisher

Cold Spring Harbor Laboratory

Subject

General Biochemistry, Genetics and Molecular Biology

Reference229 articles.

1. Suppression of Experimental Allergic Encephalomyelitis by Interferon

2. Manipulation of the Th1/Th2 Cell Balance: An Approach to Treat Human Autoimmune Diseases?

3. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice;J Immunol,1994

4. High Frequency of Autoreactive Myelin Proteolipid Protein–Specific T Cells in the Periphery of Naive Mice

5. A Transgenic Model of Central Nervous System Autoimmunity Mediated by CD4+ and CD8+ T and B Cells

Cited by 160 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vortioxetine ameliorates experimental autoimmune encephalomyelitis model of multiple sclerosis in mice via activation of PI3K/Akt/CREB/BDNF cascade and modulation of serotonergic pathway signaling;European Journal of Pharmacology;2024-11

2. Therapeutic potential of fucoidan in central nervous system disorders: A systematic review;International Journal of Biological Macromolecules;2024-10

3. A novel PROTAC molecule dBET1 alleviates pathogenesis of experimental autoimmune encephalomyelitis in mice by degrading BRD4;International Immunopharmacology;2024-09

4. Current understanding of cardiovascular autonomic dysfunction in multiple sclerosis;Heliyon;2024-08

5. Complementary strategies to be used in conjunction with animal models for multiple sclerosis drug discovery: adapting preclinical validation of drug candidates to the need of remyelinating strategies;Expert Opinion on Drug Discovery;2024-07-22